What is Omnicell's cash & equivalents?

Omnicell (OMCL) reported cash & equivalents of $290.97M in Q1 2026.

How has Omnicell's cash & equivalents changed year-over-year?

Omnicell's cash & equivalents decreased by 29.8% year-over-year, from $414.4M to $290.97M.

What is the long-term trend for Omnicell's cash & equivalents?

Over 5 years (2020 to 2025), Omnicell's cash & equivalents has grown at a -12.5% compound annual growth rate (CAGR), from $489.92M to $251.03M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Omnicell OMCL Cash & Equivalents

Cash & Equivalents at other companies

Baxter InternationalBAX

$2.02B-12.1%

Becton, Dickinson and CompanyBDX

$1.02B+49.0%

BrightSpring Health Services, Inc.BTSG

$888.8M+1,598%

Guardian Pharmacy ServicesGRDN

$64.89M+364%

Cardinal HealthCAH

$3.94B+18.4%

CencoraCOR

$2.18B+10.0%

Other financials

Income statement

See full

Revenue$309.9M+14.9%

Gross profit$140.4M+26.5%

Operating income$16.9M+245%

Net income$11.4M+262%

EPS (diluted)$0.25+267%

Balance sheet

See full

Total debt$34.3M-23.1%

Total equity$1.3B0.0%

Total assets$2.0B-6.8%

Cash flow

See full

Operating cash flow$54.5M+110%

CapEx$12.4M+11.3%

Free cash flow$42.1M+185%

Valuation

See full

Market cap$1.75B-7.2%

Enterprise value$1.49B-0.4%

P/E113.2×—

P/S1.4×-0.2×

Profitability

See full

Gross margin43.5%+0.4pp

Operating margin2.7%+1.8pp

Net margin1.7%+1.1pp

FCF margin9.3%-1.7pp

Returns & leverage

See full

Return on equity1.6%+1.1pp

Debt / equity0×0.0×

Current ratio1.5×+0.1×

Where this comes from

Reported directly by Omnicell in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Omnicell’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omnicell's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Omnicell's cash & equivalents?: Omnicell (OMCL) reported cash & equivalents of $290.97M in Q1 2026.
How has Omnicell's cash & equivalents changed year-over-year?: Omnicell's cash & equivalents decreased by 29.8% year-over-year, from $414.4M to $290.97M.
What is the long-term trend for Omnicell's cash & equivalents?: Over 5 years (2020 to 2025), Omnicell's cash & equivalents has grown at a -12.5% compound annual growth rate (CAGR), from $489.92M to $251.03M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.